NODM
Also written as: NODM — New-Onset Diabetes Mellitus
New-onset diabetes mellitus, often used interchangeably with NOD but may specifically refer to post-transplant or medication-induced diabetes. Requires careful differentiation from pre-existing diabetes.
Full Definition
New-onset diabetes mellitus (NODM) is a term commonly used in transplant medicine and cardiology to describe diabetes that develops following specific interventions or exposures. This includes post-transplant diabetes mellitus (PTDM), steroid-induced diabetes, or diabetes developing after cardiac procedures. NODM differs from stress hyperglycemia in that it represents persistent glucose intolerance rather than transient elevation. In cardiometabolic practice, NODM patients require comprehensive evaluation to determine the underlying mechanism, appropriate treatment intensity, and long-term management strategies. The development of NODM significantly impacts patient prognosis and requires multidisciplinary care coordination.
Usage
Usage note: Often context-specific to transplant or iatrogenic diabetes.
In Context
- "NODM developed three months after heart transplantation, likely related to immunosuppressive therapy." — Transplant follow-up note
- "Risk factors for NODM include family history, obesity, and high-dose corticosteroid use." — Clinical review